Potency of pertussis component in the DTP vaccine - An overview of three decade study in Poland

Biologicals

Volumn 32, Issue 3, 2004, Pages 129-137

  Gzyl, Anna ^a   Augustynowicz, Ewa ^a   Rabczenko, Daniel ^a   Gniadek, Grzegorz ^a   Ślusarczyk, Janusz ^a  

^a NATIONAL INSTITUTE OF HYGIENE   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; PERTUSSIS VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BORDETELLA PARAPERTUSSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFICACY; DRUG FORMULATION; DRUG INDUSTRY; DRUG POTENCY; DRUG SCREENING; FEMALE; INFORMATION PROCESSING; MALE; MOUSE; NONHUMAN; PERTUSSIS; POLAND; PRIORITY JOURNAL; VACCINE PRODUCTION; VIRUS STRAIN;

ADOLESCENT; ANIMALS; CHILD; DIPHTHERIA-TETANUS-PERTUSSIS VACCINE; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; FEMALE; HUMANS; MALE; MICE; POLAND; RETROSPECTIVE STUDIES; WHOOPING COUGH;

EID: 7944224326     PISSN: 10451056     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biologicals.2004.07.002     Document Type: Article

References (29)

1. E.J. Gangarosa, A.M. Gała̧zka, and C.R. Wolfe Impact of anti-vaccine movements on pertussis control: the untold story Lancet 351 1998 356 361
2. F.R. Mooi, Q. He, H. van Oirschot, and J. Mertsola Variation in the Bordetella pertussis virulence factors pertussis toxin and pertactin in vaccine strains and clinical isolates in Finland Infect Immun 67 1999 3133 3134
3. F.R. Mooi, H. van Oirschot, K. Heuvelman, H.G.J. van der Heide, W. Gaastra, and R.J.L. Willems Polymorphism in the Bordetella pertussis virulence factors P.69/pertactin and pertussis toxin in the Netherlands: temporal trends and evidence for vaccine driven evolution Infect Immun 66 1998 670 675
4. H.E. De Melker, J.F. Schellekens, S.E. Neppelenbroek, F.R. Mooi, H.C. Rumke, and M.A. Conyn-vanSpaendonck Reemergence of pertussis in the highly vaccinated population of the Netherlands: observations on surveillance data Emerg Infect Dis 6 2000 348 357
5. R. Andrews, A. Herceg, and C. Roberts Pertussis notifications in Australia, 1991 to 1997 Commun Dis Intell 21 1997 145 148
6. J.W. Bass, and R.R. Wittler Return of epidemic pertussis in the United States Pediatr Infect Dis J 13 1994 343 345
7. C. Boursaux-Eude, S. Thiberge, G. Carletti, and N. Guiso Intranasal murine model of Bordetella pertussis infection: II. Sequence variation and protection induced by a tricomponent acellular vaccine Vaccine 17 20-21 1999 2651 2660
8. P. Cassiday, G. Sanden, K. Heuvelman, F. Mooi, K.M. Bisgard, and T. Popovic Polymorphism in Bordetella pertussis pertactin and pertussis toxin virulence factors in the United States, 1935-1999 J Infect Dis 182 5 2000 1402 1408
9. K.M. Edwards Acellular pertussis vaccines - a solution to the pertussis problem? J Infect Dis 168 1 1993 15 20
10. N.K. Fry, S. Neal, T.G. Harrison, E. Miller, R. Matthews, and R.C. George Genotypic variation in the Bordetella pertussis virulence factors pertactin and pertussis toxin in historical and recent clinical isolates in the United Kingdom Infect Immun 69 9 2001 5520 5528
11. A. Gzyl, E. Augustynowicz, I. van Loo, and J. Slusarczyk Temporal nucleotide changes in pertactin and pertussis toxin genes in Bordetella pertussis strains isolated from clinical cases in Poland Vaccine 20 3-4 2000 299 303
12. P. Mastrantonio, P. Spigaglia, and H. van Oirschot Antigenic variants in Bordetella pertussis strains isolated from vaccinated and unvaccinated children Microbiology 145 1999 2069 2075
13. F.R. Mooi, H. Hallander, C.H. Wirsing von Konig, B. Hoet, and N. Guiso Epidemiological typing of Bordetella pertussis isolates: recommendations for a standard methodology Eur J Clin Microbiol Infect Dis 19 3 2000 174 181
14. C. Weber, C. Boursaux-Eude, G. Coralie, V. Caro, and N. Guiso Polymorphism of Bordetella pertussis isolates circulating for the last 10 years in France, where a single effective whole-cell vaccine has been used for more than 30 years J Clin Microbiol 39 12 2001 4397 4403
15. E. Njamkepo, F. Rimlinger, S. Thiberge, and N. Guiso Thirty-five years' experience with the whole-cell pertussis vaccine in France: vaccine strains analysis and immunogenicity Vaccine 20 9-10 2002 1290 1294
16. European Pharmacopoeia. 3rd ed.; 1997. p. 116, 1305-6.
17. P.L. Kendrick, G. Eldering, M.K. Dixon, and J. Misner Mouse protection test in the study of pertussis vaccine: a comparative series using intracerebral route of challenge Am J Public Health 37 1947 803 810
18. World Health Organization Requirements for diphtheria, tetanus, and pertussis and combined vaccines Technical report series no. 800 1990 87 168
19. P. Armitage Statistical methods in medical research 1971 Blackwell Scientific Publications Oxford
20. D.J. Finney Statistical methods in biological assay 3rd ed. 1978 Charles Griffin and Co. Ltd London
21. W.A. Shewhart Economic control of quality of manufactures product/50th Anniversary commemorative issue 1980 American Society for Quality
22. Medical Research Council Vaccination against whooping cough. Relation between protection in children and results of laboratory tests Br Med J 2 1956 454 462
23. R. Murata, F.T. Perkins, M. Pittman, I. Scheibel, and K. Sladky International collaborative studies on the pertussis vaccine potency assay. Part played by the challenge in the mouse-protection test Bull World Health Organ 44 5 1971 673 687
24. N. Dellepiane, E. Griffiths, and J.B. Milstein New challenges in assuring vaccine quality Bull World Health Organ 78 2 2000 155 160
25. World Health Organization. Informal consultation on the control of pertussis with whole cell and acellular vaccines. Geneva: WHO/V&B/99.03.
26. J.B. Milstein, B.G. Gellin, M. Kane, J.L. di Fabio, and A. Homma Global DTP manufacturing capacity and capability. Status report: January 1995 Vaccine 14 1996 313 320
27. World Health Organization. WHO guide to good manufacturing practice GMP requirements. Part 2. Validation. Geneva: WHO/VSQ/97.02.
28. D. Xing, R.G. Das, T.O. O'Neill, M. Corbel, N. Dellepiane, and J. Milstein Laboratory testing of whole cell pertussis vaccine: a WHO proficiency study using the Kendrick test Vaccine 20 2002 341 351
29. J. Slusarczyk, G. Dulny, and K. Nowak Immunization against pertussis, diphtheria and tetanus in 6-8 years old children Przegl Epidemiol 56 1 2002 39 48 [in Polish]